Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 411618Generated: October 25, 2026

(S)-Rabeprazole sodium → 2-(4-{[2-({[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methyl}sulfinyl)benzimidazol-1-yl]sulfonyl}phenoxy)-N-(2-pyridyl)acetamide

https://huagongshe.com/reaction/411618

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(S)-Rabeprazole sodiumHCID 9821387—
Reactant2-[p-(chlorosulfonyl)phenoxy]-N-(2-pyridyl)acetamideHCID 18541210—
SolventDichloromethaneHCID 6344—
SolventTriethylamineHCID 8471—
Product2-(4-{[2-({[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methyl}sulfinyl)benzimidazol-1-yl]sulfonyl}phenoxy)-N-(2-pyridyl)acetamideHCID 1031248275.2%

Reaction Steps

170 mg of 2-[p-(chlorosulfonyl)phenoxy]-N-(2-pyridyl)acetamide was added to 191 mg of 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole sodium salt in dichloromethane (15 ml) and triethylamine (0.1 ml). The reaction mixture was stirred at room temperature overnight. The reaction mixture was washed with water. Organic layer was dried over anhydrous magnesium sulfate, and evaporated. Residual material was lyophilized in vacuo to give 244 mg of the titled product.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06559167B1
Source datasetuspto-grants-2003_05
ORD IDord-8404a06165e149758b64e446a958f1e0
Source noteuspto-grants-2003_05